Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NBP176525E

Novus Biologicals™ ZMYM3 Antibody Blocking Peptide
SDP

Catalog No. NBP176525E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP176525E 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP176525E Supplier Novus Biologicals™ Supplier No. NBP176525PEP
Add to Cart
Add to Cart

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 19 amino acids near the amino terminus of human ZMYM3. Source: Synthetic (Accession #: AAH69057) The ZMYM3 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 9203
Species Human
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-76525. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias DXS6673EZinc finger protein 261 KIAA0385XFIM, MYM, zinc finger, MYM-type 3, ZNF198L2, ZNF261zinc finger MYM-type protein 3
Gene Symbol ZMYM3
Product Type ZMYM3
Quantity 0.05 mg
Regulatory Status RUO - research use only
Source Synthetic
Termination 19 amino acids near the amino terminus of human ZMYM3
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.